Literature DB >> 17363183

Antidepressants, prostaglandins and the prevention and treatment of cancer.

Julian Lieb1.   

Abstract

Among the putative mechanisms of carcinogenesis are up-regulation of cyclooxygenase, the synthesis and expression of oncogenes, viral activation, signal disruption, failed apoptosis, tumor initiation and promotion, angiogenesis, metastasis, immunosuppression, telomerase activity and autoimmunity. All are regulated by prostaglandins. Observable and radiographic regression of cancer has been documented in patients taking non-steroidal, anti-prostaglandin drugs such as indomethacin and ibuprofen. Antidepressants, too, have prostaglandin-inhibiting properties, and in vivo and in vitro evidence of their antineoplastic actions is emerging.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363183     DOI: 10.1016/j.mehy.2007.01.036

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer.

Authors:  Gregory T Wolf; Willard E Fee; Robert W Dolan; Jeffrey S Moyer; Michael J Kaplan; Paul M Spring; James Suen; Daniel E Kenady; Jason G Newman; William R Carroll; M Boyd Gillespie; Scott M Freeman; Lorraine Baltzer; Terry D Kirkley; Harvey J Brandwein; John W Hadden
Journal:  Head Neck       Date:  2011-01-31       Impact factor: 3.147

2.  Mood disorders and risk of lung cancer in the EAGLE case-control study and in the U.S. Veterans Affairs inpatient cohort.

Authors:  David E Capo-Ramos; Ying Gao; Jay H Lubin; David P Check; Lynn R Goldin; Angela C Pesatori; Dario Consonni; Pier Alberto Bertazzi; Andrew J Saxon; Andrew W Bergen; Neil E Caporaso; Maria Teresa Landi
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

3.  Anti-inflammatory activity and PGE2 inhibitory properties of novel phenylcarbamoylmethyl ester-containing compounds.

Authors:  Flora Barsoum; Hanan Georgey; Nagwa Abdel-Gawad
Journal:  Molecules       Date:  2009-02-11       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.